- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2020 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France

CITE Title : Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France Personal Author(s) : Jaspard, Marie;Butel, Nathalie;El Helali, Najoua;Marigot-Outtandy, Dhiba;Guillot, Helene;Peytavin, Gilles;Veziris, Nicolas;Bodaghi, Bahram;Flandre, Philippe;Petitjean, Gregoire;Caumes, Eric;Pourcher, Valerie; Published Date : Aug 2020 Source : Emerg Infect Dis. 26(8):1792-1800 URL : https://stacks.cdc.gov/view/cdc/91534 Jaspard, Marie et al. (2020). Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France. 26(8). Jaspard, Marie et al. "Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France" 26, no. 8 (2020) Jaspard, Marie et al. "Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France" vol. 26, no. 8, 2020 Export RIS Citation Information.

:

Jaspard, Marie ;

Butel, Nathalie

Aug 2020 | Emerg Infect Dis. 26(8):1792-1800

:

Linezolid is one of the most effective drugs for treating multidrug-resistant tuberculosis (MDR TB), but adverse effects remain problematic. We evalua...

To see more results, try removing search filters or changing the search terms